MiniMed Group Successfully Raises $560 Million in IPO Below Expected Range
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: renaissancecapital
- Funding Achievement: MiniMed Group successfully raised $560 million by offering 28 million shares at $20 each, which is below the expected range of $25 to $28, yet the company still commands a market capitalization of $5.6 billion.
- Business Focus: As a carve-out from Medtronic's diabetes management devices and technology business, MiniMed focuses on integrated diabetes management, including insulin delivery devices and continuous glucose monitors (CGMs), aiming to enhance patient quality of life.
- User Base Growth: As of October 2025, MiniMed has over 640,000 users on insulin pumps, with a CGM attachment rate reaching 65% in the six months ending October 24, 2025, up from 58% in the prior period, indicating strong market acceptance and user retention.
- Revenue Structure: Approximately 83% of total revenue is generated from CGMs, other consumables, software, and services, reflecting the durability of the company's recurring sales model, with plans to list on Nasdaq under the symbol MMED.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
